Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP
- PMID: 40514537
- PMCID: PMC12373428
- DOI: 10.1038/s41594-025-01582-w
Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP
Abstract
Despite widespread advances in DNA sequencing, the functional consequences of most genetic variants remain poorly understood. Multiplexed assays of variant effect can measure the function of variants at scale but cannot readily be applied to the ~10% of human genes encoding secreted proteins. Here we develop a flexible, scalable human cell surface display method, multiplexed surface tethering of extracellular proteins (MultiSTEP), to study the consequences of missense variation in coagulation factor IX (FIX), a serine protease in which genetic variation can cause hemophilia B. We combine MultiSTEP with a panel of antibodies to detect FIX secretion and post-translational modification (PTM), measuring 44,816 variant effects for 436 synonymous variants and 8,528 of the 8,759 possible F9 missense variants. Almost half of missense variants impact secretion, PTM or both. We also identify functional constraints on secretion within the signal peptide and for nearly all gain or loss of cysteine variants. Secretion scores correlate strongly with FIX levels in hemophilia B and reveal that loss-of-secretion variants are more often associated with severe disease. Integration of the secretion and PTM scores enables reclassification of 63.1% of F9 variants of uncertain significance in the My Life, Our Future hemophilia genotyping project. Lastly, we show that MultiSTEP can be applied to other secreted proteins, thus demonstrating that MultiSTEP is a multiplexed, multimodal and generalizable method for systematically assessing variant effects in secreted proteins at scale.
© 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests: J.P.S. was an expert witness for Genentech and Paul, Weiss, Rifkind, Wharton and Garrison. The other authors declare no competing interests.
Update of
-
Multiplex, multimodal mapping of variant effects in secreted proteins.bioRxiv [Preprint]. 2025 Jan 29:2024.04.01.587474. doi: 10.1101/2024.04.01.587474. bioRxiv. 2025. Update in: Nat Struct Mol Biol. 2025 Jun 13. doi: 10.1038/s41594-025-01582-w. PMID: 39975210 Free PMC article. Updated. Preprint.
Similar articles
-
Multiplex, multimodal mapping of variant effects in secreted proteins.bioRxiv [Preprint]. 2025 Jan 29:2024.04.01.587474. doi: 10.1101/2024.04.01.587474. bioRxiv. 2025. Update in: Nat Struct Mol Biol. 2025 Jun 13. doi: 10.1038/s41594-025-01582-w. PMID: 39975210 Free PMC article. Updated. Preprint.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Hemophilia B.2000 Oct 2 [updated 2025 Aug 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2000 Oct 2 [updated 2025 Aug 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301668 Free Books & Documents. Review.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
Cited by
-
Systematic genetic characterization of the human PKR kinase domain highlights its functional malleability to escape a poxvirus substrate mimic.bioRxiv [Preprint]. 2024 Sep 22:2024.05.29.596416. doi: 10.1101/2024.05.29.596416. bioRxiv. 2024. Update in: Elife. 2024 Nov 12;13:RP99575. doi: 10.7554/eLife.99575. PMID: 38903081 Free PMC article. Updated. Preprint.
-
Combining multiplexed functional data to improve variant classification.ArXiv [Preprint]. 2025 Mar 24:arXiv:2503.18810v1. ArXiv. 2025. PMID: 40196145 Free PMC article. Preprint.
References
Methods-only references
-
- Gibson DG et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009). - PubMed
-
- den Dunnen JT et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum. Mutat. 37, 564–569 (2016). - PubMed
-
- Miao HZ et al. Bioengineering of coagulation factor VIII for improved secretion. Blood 103, 3412–3419 (2004). - PubMed
-
- Kessler CM et al. B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study. Haemophilia 11, 84–91 (2005). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous